Pathway Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://pathwaytx.com
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
Phase 1
Completed
- Conditions
- Malignancies
- First Posted Date
- 2011-08-02
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- Pathway Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT01407380
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Sarah Cannon Research Institute, Nashville, Tennessee, United States
🇺🇸The University of Arizona Cancer Center, Tucson, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath